Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPEFree Report) in a research note released on Friday morning. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of AMPE stock opened at $0.00 on Friday. The stock has a market cap of $2,497.00, a PE ratio of 0.00 and a beta of 3.67. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $7.47. The stock has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.36.

Ampio Pharmaceuticals Company Profile

(Get Free Report)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Further Reading

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.